View in EDS HTML Full Text PDF Full Text

Lebrikizumab is associated with improvements in patient-reported symptoms and quality-of-life measures across Eczema Area and Severity Index response categories: pooled results from phase-3 randomized ADvocate1 and ADvocate2 studies in patients with moderate-to-severe atopic dermatitis

Saved in:
Bibliographic Details
Title: Lebrikizumab is associated with improvements in patient-reported symptoms and quality-of-life measures across Eczema Area and Severity Index response categories: pooled results from phase-3 randomized ADvocate1 and ADvocate2 studies in patients with moderate-to-severe atopic dermatitis
Authors: Blauvelt, Andrew1 (AUTHOR), Kircik, Leon2,3 (AUTHOR), Schlesinger, Todd4,5 (AUTHOR), Pierce, Evangeline6 (AUTHOR) evangeline.pierce@lilly.com, Burge, Russel6,7 (AUTHOR), Behling, Michael8 (AUTHOR), Atwater, Amber Reck6 (AUTHOR), ElMaraghy, Hany6 (AUTHOR), Armstrong, April9 (AUTHOR)
Source: Journal of Dermatological Treatment. Dec2025, Vol. 36 Issue 1, p1-9. 9p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 190282774
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Lebrikizumab is associated with improvements in patient-reported symptoms and quality-of-life measures across Eczema Area and Severity Index response categories: pooled results from phase-3 randomized ADvocate1 and ADvocate2 studies in patients with moderate-to-severe atopic dermatitis
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Blauvelt%2C+Andrew%22">Blauvelt, Andrew</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kircik%2C+Leon%22">Kircik, Leon</searchLink><relatesTo>2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Schlesinger%2C+Todd%22">Schlesinger, Todd</searchLink><relatesTo>4,5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pierce%2C+Evangeline%22">Pierce, Evangeline</searchLink><relatesTo>6</relatesTo> (AUTHOR)<i> evangeline.pierce@lilly.com</i><br /><searchLink fieldCode="AR" term="%22Burge%2C+Russel%22">Burge, Russel</searchLink><relatesTo>6,7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Behling%2C+Michael%22">Behling, Michael</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Atwater%2C+Amber+Reck%22">Atwater, Amber Reck</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22ElMaraghy%2C+Hany%22">ElMaraghy, Hany</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Armstrong%2C+April%22">Armstrong, April</searchLink><relatesTo>9</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Journal+of+Dermatological+Treatment%22">Journal of Dermatological Treatment</searchLink>. Dec2025, Vol. 36 Issue 1, p1-9. 9p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=190282774
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/09546634.2024.2442720
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 9
        StartPage: 1
    Titles:
      – TitleFull: Lebrikizumab is associated with improvements in patient-reported symptoms and quality-of-life measures across Eczema Area and Severity Index response categories: pooled results from phase-3 randomized ADvocate1 and ADvocate2 studies in patients with moderate-to-severe atopic dermatitis
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Blauvelt, Andrew
      – PersonEntity:
          Name:
            NameFull: Kircik, Leon
      – PersonEntity:
          Name:
            NameFull: Schlesinger, Todd
      – PersonEntity:
          Name:
            NameFull: Pierce, Evangeline
      – PersonEntity:
          Name:
            NameFull: Burge, Russel
      – PersonEntity:
          Name:
            NameFull: Behling, Michael
      – PersonEntity:
          Name:
            NameFull: Atwater, Amber Reck
      – PersonEntity:
          Name:
            NameFull: ElMaraghy, Hany
      – PersonEntity:
          Name:
            NameFull: Armstrong, April
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: Dec2025
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 09546634
          Numbering:
            – Type: volume
              Value: 36
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Journal of Dermatological Treatment
              Type: main
ResultId 1